Price to book forward of Exponent, Inc. – NASDAQ:EXPO
This article provides financial information for Exponent, Inc. (NASDAQ:EXPO), specifically focusing on its price-to-book forward ratio. It highlights that the market data is sourced from ICE Data Services and reference data from FactSet, indicating a focus on financial metrics for investors.
Price to sales forward of Exponent, Inc. – NASDAQ:EXPO
This article provides the "Price to sales forward" metric for Exponent, Inc. (NASDAQ:EXPO). The content is primarily a presentation of financial data within the TradingView platform, showing the period, value, and change percentages for this financial indicator.
Price to earnings forward of Exponent, Inc. – SWB:EP5
This article provides financial information for Exponent, Inc. (SWB:EP5) on TradingView, specifically focusing on its forward Price to Earnings ratio. It presents the latest value for this metric and indicates that the market is currently closed with no trades. The content is primarily a listing of financial data displayed on the TradingView platform.
Price to sales forward of Exponent, Inc. – SWB:EP5
This article provides the "Price to sales forward" metric for Exponent, Inc. (SWB:EP5). It shows a table with Period, Value, Change, and Change % for this financial indicator, although specific values are not displayed in the provided content. The source of the market data and other financial information is also cited.
Enterprise value to EBIT forward of Exponent, Inc. – NASDAQ:EXPO
This article focuses on the enterprise value to EBIT forward ratio for Exponent, Inc. (NASDAQ:EXPO). It is a financial data point presented within a larger financial platform context, offering an overview of the company's valuation metric. The content itself seems to be a specific data display rather than an analytical article.
Exponent (EXPO) CEO exercises 7,872 options, holds 115,129 shares
Exponent Inc. CEO Catherine Corrigan exercised stock options to acquire 7,872 shares of common stock at an effective price of $25.405 per share. Following this transaction, Corrigan directly holds 115,129 shares of Exponent common stock. The exercise was an "exercise-and-hold" transaction, with no shares reported sold.
EXPO Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Exponent, Inc. (EXPO) stock for 2027, based on analyst ratings and financial data. It includes details on the current stock price, historical performance, market capitalization, earnings, revenue, and dividend information, along with frequently asked questions about investing in EXPO.
Exponent, Inc. Actuals & Estimates (NASDAQ:EXPO)
This article provides an overview of Exponent, Inc. (NASDAQ: EXPO) stock, including its current price, historical performance, analyst forecasts, and financial data. It details the company's recent earnings, revenue, dividends, market capitalization, and volatility, while also offering guidance on how to interpret its financials and technical analysis.
EXPO: AI Failure Analysis And Buybacks Will Support Premium Future P/E
Analysts have reduced Exponent's (EXPO) price target from $90 to approximately $81.67, with some citing macro uncertainty and a preference for companies with more visible growth drivers. However, bullish analysts still maintain an "Overweight" stance, believing the valuation is reasonable given the company's execution and potential, particularly with upcoming AI infrastructure and
Exponent Inc (EXPO) Institutional Confidence
Exponent Inc's institutional shareholding score remains at 10.00, ranking it first in the Professional & Commercial Services industry. The company's institutional shareholding proportion is 99.35%, a slight decrease of 1.19% quarter-over-quarter. Chuck Royce is the largest institutional shareholder, holding 2.32% of outstanding shares.
Exponent president & CEO Catherine Corrigan sells $235k in stock By Investing.com
Exponent Inc.'s President and CEO, Catherine Corrigan, sold shares worth $235,303 on June 15, 2026, after exercising stock options. The sale involved 4,119 shares at $57.1263 each, closely aligning with the current stock price despite a 17% year-to-date decline, though InvestingPro suggests the stock is undervalued. Corrigan also acquired 5,605 shares through non-qualified stock options prior to the sale and now holds 107,257 shares directly.
Exponent to Host Investor Day at Phoenix Test & Engineering Center
Exponent, Inc. (Nasdaq: EXPO) announced it will host an Investor Day on September 29, 2026, at its Phoenix Test & Engineering Center. The event will feature presentations from leadership on premium service offerings, multidisciplinary solutions, and growth opportunities, including those driven by AI infrastructure. Attendees will also tour the facility to see advanced testing and engineering capabilities firsthand.
Exponent president & CEO Catherine Corrigan sells $235k in stock
Exponent Inc.'s President and CEO, Catherine Corrigan, sold 4,119 shares of company stock for $235,303 after exercising stock options. These transactions, occurring on June 15, 2026, involved covering the exercise price and associated taxes. Following these sales, Ms. Corrigan directly holds 107,257 Exponent common shares, with the stock currently considered undervalued according to InvestingPro analysis despite being down 17% year-to-date.
Exponent president & CEO Catherine Corrigan sells $235k in stock
Exponent Inc. President and CEO Catherine Corrigan sold 4,119 shares of company stock for $235,303 on June 15, 2026, after exercising stock options. The sale was partly to cover exercise costs and taxes. Ms. Corrigan now directly holds 107,257 shares, and the company's stock is considered undervalued by InvestingPro, despite an earlier rise in aftermarket trading following strong Q1 2026 earnings.
Exponent president & CEO Catherine Corrigan sells $235k in stock By Investing.com
Exponent Inc. (NASDAQ:EXPO) President and CEO Catherine Corrigan sold $235,303 worth of company shares after exercising stock options on June 15, 2026. Prior to the sale, she acquired 5,605 shares through option exercises valued at $151,070. Following these transactions, Corrigan directly holds 107,257 shares, and the company has recently reported strong Q1 2026 earnings and raised its dividend for 13 consecutive years.
Exponent (EXPO) CEO exercises 5,605 options, sells shares to cover taxes
Exponent Inc.'s President & CEO, Catherine Corrigan, recently exercised 5,605 non-qualified stock options at exercise prices of $29.05 and $25.405 per share. On the same day, she sold 4,119 shares at an average price of $57.1263 per share to cover the option exercise costs and taxes. Following these transactions, Corrigan directly holds 106,670 shares of Exponent common stock.
Exponent to Host Investor Day at Phoenix Test & Engineering Center
Exponent, Inc. announced it will host an Investor Day at its Phoenix Test & Engineering Center on September 29, 2026. The event will showcase the company's scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy, with a focus on supporting clients amidst the complexities of AI and emerging technologies. Leadership will present on key aspects of Exponent's differentiated model, including its extensive technical disciplines and expertise in failure analysis, testing, and reliability.
Exponent Inc (EXPO) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Exponent Inc (EXPO), which currently holds a risk score of 9.09, placing it 17th out of 161 in the Professional & Commercial Services industry. The company's beta of 0.74 suggests it generally underperforms in rising markets but experiences smaller declines in falling markets. The assessment also includes various financial metrics such as VaR, maximum drawdown, volatility, Sharpe ratio, skewness, and liquidity data for different timeframes.
Exponent to Host Investor Day at Phoenix Test & Engineering Center
Exponent, Inc. (Nasdaq: EXPO) announced it will host an Investor Day at its Phoenix Test & Engineering Center on September 29, 2026. The event will showcase the company's scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy, particularly in areas like AI infrastructure. The program aims to highlight Exponent's value proposition in addressing complex challenges at the intersection of hardware, software, AI-enabled systems, and human behavior.
Exponent Inc (EXPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Exponent Inc (EXPO), focusing on its regional revenue contributions. As of April 6, the company's financial data for FY2025-2019 stated that relevant business segment and other regional data have not yet been disclosed. The United States accounts for 89.45% of its revenue, while foreign countries contribute 10.55%.
Exponent Inc (EXPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Exponent Inc (EXPO), highlighting its current price momentum score of 7.12 and its trading range between resistance at 60.22 and support at 54.01. It details various technical indicators (MACD, RSI, KDJ, etc.) and moving averages (MA5 to MA200), concluding with a "Sell" signal based on the combined analysis. The report also includes FAQs about technical ratings and moving averages.
Exponent Inc (EXPO) Earnings Forecast: Future EPS & Revenue Growth Estimates
Exponent Inc (EXPO) has an earnings forecast score of 8.00, ranking 33 out of 161 in its industry. Analysts have an average target price of $83.00 for EXPO, with a consensus "Buy" rating based on four analysts. The company's expected revenue for the next quarter is $147.54 million, and the estimated EPS is $0.55.
EXPO (NASDAQ: EXPO) — Notice to Sell 4,119 Shares; 10b5-1 Sales Listed
A Form 144 notice has been filed by Morgan Stanley Smith Barney LLC on June 15, 2026, proposing the sale of 4,119 shares of EXPO common stock, stemming from an exercise of stock options with cash consideration. The filing also details prior 10b5-1 sales made by Catherine Corrigan on three separate dates in March, April, and May 2026, involving similar share quantities. These filings provide transparency on insider share dispositions, with the proposed sale's execution dependent on regulatory compliance.
Exponent Inc Stock (US30214U1025): valuation and fundamentals in focus after recent sell-off
Exponent Inc (EXPO) has seen its stock pull back significantly, prompting a reevaluation of its valuation, profitability, and balance sheet by investors. Despite consistent profitability and a strong balance sheet with no significant long-term debt, the project-based revenue model and previously high trading multiple are now being scrutinized in an environment of higher interest rates and sector rotation. The company's specialized expertise, diversified client base, and strong margins remain key strengths, but market participants are balancing these against growth expectations and valuation relative to peers.
[8-K] EXPONENT INC Reports Material Event
Exponent, Inc. (NASDAQ: EXPO) held its annual shareholder meeting on June 4, 2026, where stockholders elected six directors, ratified KPMG LLP as the independent accounting firm for fiscal year 2027, and approved the 2025 executive compensation on an advisory basis. Karen A. Richardson was appointed Chairman of the Board, and committee memberships were updated. The company reported 48,614,692 shares outstanding as of the record date.
EXPO Technical Analysis & Stock Price Forecast
An AI-driven technical analysis for Exponent Inc (EXPO) as of June 8, 2026, indicates a "Sell" sentiment. The analysis, which aggregates 11 technical signals, shows 4 buy indicators and 7 sell indicators. Key metrics like the MACD and several moving averages point to a bearish outlook, with the stock trading below its 60-day and 200-day moving averages.
Is Exponent, Inc. (EXPO) A Good Stock To Buy Now?
This article analyzes Exponent, Inc. (EXPO), a highly specialized science and engineering consulting firm, based on a bullish thesis. It highlights EXPO's strong competitive moat due to deep technical expertise, litigation-grade analysis, and its position within legal and regulatory ecosystems. The article discusses EXPO's financial strengths, including high EBIT margins, zero debt, and consistent free cash flow, while also noting current valuation relative to historical averages and the potential for rerating.
Exponent leadership to join Wells Fargo Industrials conference
Exponent, Inc.'s leadership team, including CEO Dr. Catherine Corrigan and President John Pye, will participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference on June 9, 2026, at 12:00 p.m. ET. The event will be webcast live on the company's investor relations website. Exponent, leveraging diverse technical disciplines, aims to engage with the investment community and discuss solutions for various industries.
Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
Exponent, Inc. (EXPO) announced its participation in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference. The event is scheduled for Tuesday, May 7, 2024, at 11:20 AM ET, and will feature President and CEO Dr. Catherine Corrigan and CFO Richard Schuler. A webcast of the chat will be accessible on Exponent's investor relations website.
Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
Exponent, Inc. will participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference on Tuesday, June 9, 2026. CEO Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and CFO Eric Anderson will represent the company. A webcast of the event will be available on Exponent's investor relations website.
Exponent leadership hosts fireside chat at Wells Fargo investor conference
Exponent (Nasdaq: EXPO) announced that its CEO, President, EVP, and CFO will participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference on June 9, 2026, at 12:00 p.m. ET. A live webcast and archived replay will be available on Exponent’s investor relations website. This event offers investors an opportunity to hear from senior leadership about the company's strategy and outlook amidst recent mixed market reactions to positive corporate updates.
Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
Exponent, Inc. announced that its CEO, President, Executive VP, and CFO will take part in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference on June 9, 2026. A webcast of the presentation will be available on the investor relations section of Exponent's website. Exponent is a company that provides scientific and engineering consulting services across various industries.
Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
Exponent, Inc. (Nasdaq: EXPO) announced that its CEO, President, Executive Vice President, and CFO will participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference on June 9, 2026. A webcast of the presentation will be available on the investor relations section of the company's website. Exponent is a company that provides scientific and engineering consulting services across various industries.
Exponent (EXPO) director exercises 2,009 RSUs into 62,940-share stake
Exponent Inc. director Paul R. Johnston converted 2,009 Restricted Stock Units (RSUs) into common stock on June 3, 2026. These RSUs were granted on June 5, 2025, and converted on a 1-for-1 basis without an open-market transaction. Following this conversion, Johnston directly holds 62,940 shares of Exponent common stock.
Exponent (NASDAQ: EXPO) director receives 2,859 RSUs and exercises 2,009 into common stock
Exponent Inc. director Debra Zumwalt received 2,859 Restricted Stock Units (RSUs) on June 4, 2026, which will cliff-vest before the next annual shareholder meeting. On June 3, 2026, she exercised 2,009 RSUs into common stock, bringing her direct holdings to 31,830 shares. The reported transactions are routine equity compensation activities and do not involve any share sales.
Exponent (NASDAQ: EXPO) director gets 2,859 RSUs, exercises 2,009 shares
Exponent Inc. director George H. Brown received a grant of 2,859 Restricted Stock Units (RSUs) on June 4, 2026, which will vest before the company's next annual shareholder meeting. Additionally, on June 3, 2026, he exercised 2,009 previously vested RSUs into Common Stock, increasing his direct holdings to 10,730 shares. These transactions are part of his equity compensation and are not open-market trades.
Exponent (Nasdaq:EXPO) - Stock Analysis
This analysis of Exponent (EXPO) highlights that the company is undervalued by 33.7% according to analyst consensus and is trading at a discount below its fair value estimate. Exponent is a scientific and engineering consulting firm with a strong dividend history, good financial health, and expected earnings growth. However, it faces risks such as significant insider selling and recent share price underperformance compared to the market.
Exponent (EXPO) director adds equity via 2,859 RSU grant and 2,009-share exercise
Exponent Inc. director Carol Lindstrom reported receiving a grant of 2,859 Restricted Stock Units (RSUs) that will cliff-vest before the next annual shareholder meeting. She also exercised 2,009 previously granted RSUs, converting them into common stock shares. Following these compensation-related transactions, Lindstrom directly holds 9,405 shares of Common Stock.
Exponent (EXPO) Gets a Hold from UBS
UBS analyst Joshua Chan maintained a Hold rating on Exponent (EXPO) with a $75.00 price target. The company recently reported strong quarterly revenue and net profit but insider sentiment is negative due to increased selling activity. Exponent currently holds a "Strong Buy" analyst consensus.
Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Exponent (EXPO), XPO (XPO) and Firefly Aerospace, Inc. (FLY)
This article summarizes recent analyst ratings for three industrial goods stocks: Exponent (EXPO), XPO (XPO), and Firefly Aerospace, Inc. (FLY). While Exponent received a "Hold" rating from UBS and a "Strong Buy" consensus, XPO was assigned a "Hold" by Susquehanna with a "Moderate Buy" consensus. Firefly Aerospace, Inc. maintained a "Buy" rating from Roth MKM, also with a "Moderate Buy" overall consensus.
UBS reiterates Neutral rating on Exponent stock at $75 target
UBS has reiterated its Neutral rating on Exponent (NASDAQ:EXPO) stock, setting a $75.00 price target. The consulting firm's management discussed the potential impact of artificial intelligence, stating Exponent is protected from AI disruption due to its expertise in solving complex, unstructured problems. Despite the stock trading below InvestingPro’s Fair Value estimate and a 12.69% year-to-date decline, UBS noted that AI risk appears lower for Exponent compared to most professional services companies, maintaining its rating due to shares trading at 17 times EBITDA.
UBS reiterates Neutral rating on Exponent stock at $75 target By Investing.com
UBS has reiterated a Neutral rating on Exponent (NASDAQ:EXPO) stock with a $75.00 price target. The firm noted that investor focus has shifted towards the potential impact of artificial intelligence, but Exponent's management believes the company is protected due to its expertise in solving unstructured problems. Despite the stock trading below InvestingPro’s Fair Value estimate and declining 12.69% year-to-date, UBS maintains its rating, citing shares trading at 17 times EBITDA.
UBS reiterates Neutral rating on Exponent stock at $75 target
UBS has reiterated a Neutral rating on Exponent (NASDAQ:EXPO) stock with a $75.00 price target, noting that the firm's shares trade at 17 times EBITDA despite a recent de-rating. The company's management addressed investor concerns regarding AI disruption, asserting protection due to their expertise in unstructured problem-solving. Exponent recently surpassed market expectations in its first-quarter 2026 earnings with an EPS of $0.57 and revenue of $144.47 million.
Exponent group VP James Bradley sells $114,930 in common stock
James Bradley A, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 2,000 shares of the company's common stock for $114,930 on May 26, 2026, at a price of $57.465 per share. This transaction leaves Mr. Bradley A with 1,105 shares. The sale occurred while Exponent shares have declined by 24.6% over the past year, trading near their 52-week low, despite an InvestingPro analysis suggesting the stock is undervalued and recent strong first-quarter 2026 earnings.
Exponent group VP James Bradley sells $114,930 in common stock By Investing.com
James Bradley A, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 2,000 shares of company common stock worth $114,930 on May 26, 2026. This sale leaves him with 1,105 shares, and occurred while the stock has seen a 24.6% decline over the past year, trading near its 52-week low. Despite the recent dip, InvestingPro analysis indicates the stock is undervalued, while Exponent Inc. recently reported first-quarter earnings that surpassed market expectations.
Exponent group VP James Bradley sells $114,930 in common stock By Investing.com
James Bradley, Group Vice President at Exponent Inc., sold 2,000 shares of the company's common stock for a total of $114,930 on May 26, 2026. This transaction occurred as the company's stock has declined by 24.6% over the past year, though an InvestingPro analysis suggests it is undervalued. Exponent recently reported strong first-quarter 2026 earnings, exceeding market expectations for EPS and meeting revenue projections.
Insider Sell: Bradley James Sells 2,000 Shares of Exponent Inc (EXPO)
Bradley James, Group Vice President at Exponent Inc (EXPO), sold 2,000 shares of the company on May 26, 2026, reducing his holdings to 1,105 shares. Over the past year, Exponent Inc has seen 16 insider sells and no insider buys. The stock is currently priced at $57.47, with a GF Value of $92.41, indicating it is significantly undervalued.
Exponent group VP James Bradley sells $114,930 in common stock
James Bradley A, Group Vice President at Exponent Inc. (NASDAQ:EXPO), sold 2,000 shares of company stock for $114,930 on May 26, 2026. This transaction leaves him with 1,105 shares, occurring while Exponent shares are near a 52-week low despite recent strong Q1 2026 earnings that exceeded analyst expectations. InvestingPro analysis suggests the stock is currently undervalued.
Exponent (NASDAQ: EXPO) vice president sells 2,000 shares in open trade
Exponent Inc.'s Group Vice President, James Bradley, sold 2,000 shares of common stock in an open-market transaction on May 26, 2026, at an average price of $57.465 per share. Following this transaction, Bradley directly holds 1,105 shares of the company's common stock. This sale, valued at approximately $114,930, was reported in a Form 4 filing and is considered to have a moderate impact with a negative sentiment.
Form 144: EXPO (NASDAQ) — 2,000 restricted shares reported by Morgan Stanley
Morgan Stanley Smith Barney LLC Executive Financial Services has filed a Form 144 notice indicating the proposed sale of 2,000 restricted shares of Common Stock for EXPO (NASDAQ). The shares are comprised of two blocks, 1,580 and 420 shares, both dated March 11, 2026, with a listed market of NASDAQ and a filing date of May 26, 2026. This filing is neutral in sentiment and impact, acting as a transparency measure for potential future sales without detailing immediate transaction specifics or proceeds.
